Digestive and biliary disorders:

Indications for VIOKACE:

Treatment of exocrine pancreatic insufficiency in adults due to chronic pancreatitis or pancreatectomy, in combination with a proton pump inhibitor.


Start at the lowest recommended dose and increase gradually. Individualize based on clinical symptoms, the degree of steatorrhea present, and the fat content of the diet. Swallow whole; do not crush or chew tabs. Take with meals and sufficient fluid. Do not let any drug remain in mouth. Initially 500 lipase units/kg per meal. Max: 2500 lipase units/kg per meal (or ≤10000 lipase units/kg/day), or <4000 lipase units/g fat ingested per day. See full labeling.


Not established.


Not interchangeable with other pancrelipase products. Fibrosing colonopathy (with high doses); risk of stricture formation (monitor). Pork allergy. Potential viral transmission. Gout. Renal impairment. Hyperuricemia. Contents irritating to oral mucosa. Lactose intolerance. Pregnancy (Cat.C). Nursing mothers.

Pharmacologic Class:

Pancreatic enzymes (porcine).

Adverse Reactions:

Biliary tract stones, anal pruritus; allergic reactions.

How Supplied:


Pricing for VIOKACE

20880 units tablet (Qty: 90)
Appx. price $542